1. Home
  2. SCSC vs WVE Comparison

SCSC vs WVE Comparison

Compare SCSC & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ScanSource Inc.

SCSC

ScanSource Inc.

HOLD

Current Price

$54.65

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$5.32

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCSC
WVE
Founded
1992
2012
Country
United States
Singapore
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
1997
2015

Fundamental Metrics

Financial Performance
Metric
SCSC
WVE
Price
$54.65
$5.32
Analyst Decision
Hold
Strong Buy
Analyst Count
1
16
Target Price
$43.00
$29.81
AVG Volume (30 Days)
247.4K
3.1M
Earning Date
05-07-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
21.33
N/A
EPS
3.64
N/A
Revenue
$3,846,260,000.00
$3,704,000.00
Revenue This Year
$2.60
N/A
Revenue Next Year
$4.01
$85.67
P/E Ratio
$23.30
N/A
Revenue Growth
7.79
149.43
52 Week Low
$33.76
$5.01
52 Week High
$66.78
$21.73

Technical Indicators

Market Signals
Indicator
SCSC
WVE
Relative Strength Index (RSI) 51.22 44.16
Support Level $39.23 $5.02
Resistance Level $59.60 $6.39
Average True Range (ATR) 2.69 0.34
MACD -0.23 -0.02
Stochastic Oscillator 27.66 23.93

Price Performance

Historical Comparison
SCSC
WVE

About SCSC ScanSource Inc.

ScanSource Inc provides value-added services for technology manufacturers and sells to resellers in specialty technology markets. The firm's operations are organized in two segments: Specialty Technology Solutions and Intelisys & Advisory Segment. It generates maximum revenue from the Specialty Technology Solutions segment. The Specialty Technology Solutions segment includes the company's business in mobility and barcode, POS, payments, security and networking technologies. Geographically, it derives a majority of revenue from the United States and Canada, and also has its presence in Brazil, and other countries.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: